These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19569031)

  • 1. Fibroblast growth factor 23 (FGF23) and the kidney.
    Tsagalis G; Psimenou E; Manios E; Laggouranis A
    Int J Artif Organs; 2009 Apr; 32(4):232-9. PubMed ID: 19569031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
    Goldsweig BK; Carpenter TO
    Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphatonin pathway: new insights in phosphate homeostasis.
    Schiavi SC; Kumar R
    Kidney Int; 2004 Jan; 65(1):1-14. PubMed ID: 14675031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatonins: From Discovery to Therapeutics.
    Kritmetapak K; Kumar R
    Endocr Pract; 2023 Jan; 29(1):69-79. PubMed ID: 36210014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin.
    Fukumoto S; Yamashita T
    Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):385-9. PubMed ID: 12105387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
    Larsson T; Marsell R; Schipani E; Ohlsson C; Ljunggren O; Tenenhouse HS; Jüppner H; Jonsson KB
    Endocrinology; 2004 Jul; 145(7):3087-94. PubMed ID: 14988389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia.
    Kumar R
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):547-53. PubMed ID: 12187320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FGF23 and bone metabolism].
    Ito N; Fukumoto S
    Clin Calcium; 2005 Jul; 15(7):43-8. PubMed ID: 15995295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.
    Shaikh A; Berndt T; Kumar R
    Pediatr Nephrol; 2008 Aug; 23(8):1203-10. PubMed ID: 18288501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF23 and Associated Disorders of Phosphate Wasting.
    Gohil A; Imel EA
    Pediatr Endocrinol Rev; 2019 Sep; 17(1):17-34. PubMed ID: 31599133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting.
    Bacchetta J; Bardet C; Prié D
    Metabolism; 2020 Feb; 103S():153865. PubMed ID: 30664852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
    Fukumoto S
    Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23 and syndromes of abnormal renal phosphate handling.
    Bergwitz C; Jüppner H
    Adv Exp Med Biol; 2012; 728():41-64. PubMed ID: 22396161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.